Hamed Samavat

Dr. Hamed Samavat

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cancer Letters
Verified
Journal Article
Closed access
HSHamed Samavat
Hamed Samavat
MKMindy S. Kurzer
Mindy S. Kurzer

30 September 2022 in Journal of Dietary Supplements
Verified
Journal Article
Closed access
LALaura Acosta
Laura Acosta
LBLaura Byham-Gray
Laura Byham-Gray
MKMindy Kurzer
Mindy Kurzer
HSHamed Samavat
Hamed Samavat
Green tea, produced from the Camellia sinensis plant, has been used for medicinal purposes in east Asia for thousands of years (1), and in the past several decades has shown promise for its potenti...

19 July 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
HSHamed Samavat
Hamed Samavat
HLHung N. Luu
Hung N. Luu
KBKenneth B. Beckman
Kenneth B. Beckman
AJAizhen Jin
Aizhen Jin
RWRenwei Wang
Renwei Wang
Jian-Min YuanJian-Min Yuan
Jian-Min Yuan

17 April 2019 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
HSHamed Samavat
Hamed Samavat
XXXiaoshuang Xun
Xiaoshuang Xun
AJAizhen Jin
Aizhen Jin
RWRenwei Wang
Renwei Wang
WKWoon Puay Koh
Woon Puay Koh
Jian-Min YuanJian-Min Yuan
Jian-Min Yuan
Telomeres and telomerase play key roles in the chromosomal maintenance and stability. Recent epidemiological studies have shown that longer telomeres are associated with increased risk of several cancer types. However, epidemiological data for telomere length and risk of breast cancer are sparse. We prospectively studied the association between telomere length and risk of breast cancer in 14,305 middle-aged or older Chinese women of the Singapore Chinese Health Study including 442 incident breast cancer cases after 12.3 years of follow-up. Relative telomere length in peripheral blood leukocytes was quantified using a validated monochrome multiple quantitative polymerase chain reaction method. The Cox proportional hazard regression method was used to estimate hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) for breast cancer associated with longer telomeres after adjustment for potential confounders. Longer telomeres were significantly associated with higher risk of breast cancer in a dose-dependent manner (Ptrend = 0.006); the highest quartile of telomere length was associated with a statistically significant 47% higher risk of breast cancer compared with the lowest quartile of telomere length after the adjustment for age and other known risk factors for breast cancer (HRQ4 vs Q1 = 1.47, 95% CI = 1.11, 1.94). The findings of the present study support the hypothesis that longer telomeres may be a risk factor for breast cancer. Telomere length in peripheral blood leukocytes may be developed as a biomarker for breast cancer risk prediction.

30 March 2019 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
HSHamed Samavat
Hamed Samavat
AWAnna H Wu
Anna H Wu
GUGiske Ursin
Giske Ursin
CTCarolyn J Torkelson
Carolyn J Torkelson
RWRenwei Wang
Renwei Wang
Jian-Min YuanJian-Min Yuan
Jian-Min Yuan
Consumption of green tea has been associated with reduced risk of breast cancer. Hormonal modulation has been suggested as one of the potential underlying mechanisms; however, it has yet to be fully elucidated in large, long-term human clinical trials. We investigated the effects of decaffeinated green tea extract (GTE) on circulating sex hormones and insulin-like growth factor (IGF) proteins. We conducted a placebo-controlled double-blind randomized clinical trial recruiting from 8 clinical centers in Minnesota. Participants were 538 healthy postmenopausal women randomly assigned to the GTE group (463 completed the study; mean age = 60.0 y) and 537 to the placebo group (474 completed; mean age = 59.7 y). Women in the GTE group orally took 4 decaffeinated capsules containing 1315 mg total catechins including 843 mg epigallocatechin-3-gallate daily for 1 y, whereas women in the placebo group took similar capsules containing no tea catechins. Blood sex hormones (estrone, estradiol, androstenedione, testosterone, and sex hormone-binding globulin) and IGF proteins (IGF-1 and IGF binding protein-3) were quantified at baseline and months 6 (for IGF proteins only) and 12, and were assessed as secondary outcomes of the study using a mixed-effect repeated-measures ANOVA model. Women in the GTE group had significantly higher blood total estradiol (16%; P = 0.02) and bioavailable estradiol (21%; P = 0.03) than in the placebo group at month 12. There was a statistically significant interaction between GTE supplementation and duration of treatment on estradiol and bioavailable estradiol (both Ps for interaction = 0.001). The catechol-O-methyltransferase genotype did not influence blood sex hormones before or after GTE supplementation. The circulating concentrations of IGF proteins were comparable between GTE and placebo groups at all 3 time points. These results suggest that a 12-mo GTE supplementation significantly increases circulating estradiol concentrations in healthy postmenopausal women. This trial was registered at clinicaltrials.gov as NCT00917735.

1 January 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAnca Cunningham
Anca Cunningham
AGAllison Gomes
Allison Gomes
LMLingqiong Meng
Lingqiong Meng
SSSue Shapses
Sue Shapses
LBLaura Byham-Gray
Laura Byham-Gray
HSHamed Samavat
Hamed Samavat
Background: Excess adiposity induces low-grade inflammation, including increased C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Green tea contains epigallocatechin gallate (EGCG), with anti-inflammatory potential. EGCG metabolism is influenced by individual variations in catechol-O-methyltransferase (COMT) genotypes. Objectives: To evaluate the effect of green tea extract (GTE) supplementation on circulating inflammatory cytokines among postmenopausal women with overweight or obesity and differing COMT genotypes. Methods: This study is a secondary analysis of a random subset (N = 97) from the Minnesota Green Tea Trial (MGTT), a randomized double-blinded placebo-controlled trial. The intervention was a high-dose GTE supplement (843 ± 44 mg EGCG/day) or placebo for 1 year. Serum CRP, TNF-α, and IL-6 were measured at 0, 6, and 12 months. Absolute changes in inflammatory cytokines from baseline to month 12 were evaluated using linear mixed-effects models adjusted for age, body mass index (BMI), smoking history, physical activity, and vitamin supplement use. Results: The changes from month 0 to month 12 were not statistically different between the groups for any of the inflammatory cytokines measured. The overall treatment effect was not statistically significant for CRP (p = 0.24), IL-6 (p = 0.59), TNF-α (p = 0.36), nor for the interaction between treatment group and time (all Ps > 0.40). There was no significant interaction between treatment group and COMT genotype for the stated markers. Conclusions: A high-dose GTE supplement consumed daily for one year did not significantly decrease inflammatory cytokines among postmenopausal women with overweight or obesity. The COMT genotype did not modify the effects of GTE supplementation on inflammatory cytokines. Future studies with a larger sample size among those at high risk of systemic inflammation are warranted.